Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.255 USD | -2.38% | -7.08% | -3.88% |
May. 09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.88% | 283M | |
+18.29% | 125B | |
+13.90% | 109B | |
-3.41% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-11.57% | 16.64B | |
+0.09% | 13.45B | |
+22.24% | 11.32B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Citigroup Upgrades Mersana Therapeutics to Buy From Neutral, Raises Price Target to $5 From $1